Alberto sales up 11.6% to $347.6 mil. in first FY 1996 quarter.
This article was originally published in The Rose Sheet
Executive Summary
ALBERTO SALES ADVANCE 11.6% TO $347.6 MIL. IN FIRST QUARTER of FY 1996 (ended Dec. 31) as gains from the company's International and Sally Beauty businesses offset declines in the USA group, the Melrose Park, IL-based firm reported Jan. 25. Net earnings for the quarter grew 15% to $12.9 mil
You may also be interested in...
Alberto-Culver sales up 22.2% to $396.1 mil. in second quarter 1996.
ALBERTO-CULVER USA EARNINGS UP OVER 60% ON 20% SALES GAIN IN SECOND QUARTER of FY 1996 (ended March 31), the Melrose Park, Ill.-based company said April 25. The firm pointed to the acquisition of St. Ives, which includes the Swiss Formula hair and skin care brands, as "playing an important part in supplementing growth of the company's core brands and businesses."
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.